Advertisement
Article| Volume 36, ISSUE 4, P435-441, April 2018

Download started.

Ok

Poor ovarian response as a predictor for live birth in older women undergoing IVF

Published:February 01, 2018DOI:https://doi.org/10.1016/j.rbmo.2018.01.008

      Abstract

      Women of advanced age present a major challenge for fertility treatments. This study was designed to assess whether poor ovarian response (POR) according to the Bologna criteria is a significant predictor for live birth in women over 40. The outcomes of subsequent IVF cycles were also studied. The results of 1870 fresh IVF cycles in 1212 women were retrospectively analysed. The live birth per cycle was 3.3 times higher (11.61% versus 3.54%, P < 0.001) in good responders with more than three oocytes collected compared with women with less. Ovarian response defined by oocytes collected, but not by the number of follicles, was independently associated with live birth (odds ratio, 2.0; 95% confidence interval, 1.18 to 3.54; P = 0.009). The occurrence of POR in subsequent IVF cycles was only 55%. No differences in live births were found in persistent POR compared with women with at least one good response. A single episode of POR in a first IVF cycle in older women has a limited predictive value for the outcomes of subsequent cycles. POR in women aged 40–43 years, defined by the number of oocytes retrieved, is a predictor for live birth in IVF.

      Keywords

      Introduction

      As more women delay childbearing, women at the age of 40 and over present a major challenge for fertility treatments. Spontaneous live birth rate decreases dramatically in this age group and, even with IVF, the live birth rate for this subgroup of patients is around 10% (
      • Crawford S.
      • Boulet S.L.
      • Kawwass J.F.
      • Jamieson D.J.
      • Kissin D.M.
      Cryopreserved oocyte versus fresh oocyte assisted reproductive technology cycles, United States, 2013.
      ,
      • Sunderam S.
      • Kissin D.M.
      • Crawford S.B.
      • Folger S.G.
      • Jamieson D.J.
      • Warner L.
      • Barfield W.D.
      Assisted reproductive technology surveillance – United States, 2014.
      ). Earlier single-centre studies reported a live birth rate of 2.0–13.9% for women between the ages of 40 and 43 (
      • Klipstein S.
      • Regan M.
      • Ryley D.A.
      • Goldman M.B.
      • Alper M.M.
      • Reindollar R.H.
      One last chance for pregnancy: a review of 2,705 in vitro fertilization cycles initiated in women age 40 years and above.
      ,
      • Lass A.
      • Croucher C.
      • Duffy S.
      • Dawson K.
      • Margara R.
      • Winston R.M.L.
      One thousand initiated cycles of in vitro fertilization in women > or = 40 years of age.
      ,
      • Serour G.
      • Mansour R.
      • Serour A.
      • Aboulghar M.
      • Amin Y.
      • Kamal O.
      • Al-Inany H.
      • Aboulghar M.
      Analysis of 2,386 consecutive cycles of in vitro fertilization or intracytoplasmic sperm injection using autologous oocytes in women aged 40 years and above.
      ,
      • Tsafrir A.
      • Simon A.
      • Revel A.
      • Reubinoff B.
      • Lewin A.
      • Laufer N.
      Retrospective analysis of 1217 IVF cycles in women aged 40 years and older.
      ).
      The decline in fertility in older women over 40 is caused both by reduced ovarian reserve caused by accelerated follicular loss (
      • Faddy M.J.
      • Gosden R.G.
      • Gougeon A.
      • Richardson S.J.
      • Nelson J.F.
      Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause.
      ), as well as by a higher rate of chromosomal abnormalities and cytoplasmic dysfunction, such as mitochondrial dysfunction (
      • Hassold T.
      • Hunt P.
      Maternal age and chromosomally abnormal pregnancies: what we know and what we wish we knew.
      ,
      • Miao Y.-L.
      • Kikuchi K.
      • Sun Q.-Y.
      • Schatten H.
      Oocyte ageing: cellular and molecular changes, developmental potential and reversal possibility.
      ). These destructive mechanisms will ultimately lead to lower pregnancy rates and higher pregnancy losses. Poor ovarian response (POR) to ovarian stimulation is defined either by ovarian reserve tests such as Day 3 FSH, antral follicle count (AFC), the number of growing follicles during controlled ovarian stimulation or, alternatively, following ovum pickup, by the number of oocytes retrieved. Since 2011, the accepted definition for women with POR is the Bologna criteria (
      • Ferraretti A.P.
      • La Marca A.
      • Fauser B.C.J.M.
      • Tarlatzis B.
      • Nargund G.
      • Gianaroli L.
      ESHRE consensus on the definition of ‘poor response to ovarian stimulation for in vitro fertilization: the Bologna criteria.
      ).
      The success rate of IVF is correlated with the ovarian response and the number of oocytes retrieved (
      • Sunkara S.K.
      • Rittenberg V.
      • Raine-Fenning N.
      • Bhattacharya S.
      • Zamora J.
      • Coomarasamy A.
      Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles.
      ). Nevertheless, few studies have evaluated the outcome of IVF in women over 40 according to their ovarian response.
      • Biljan M.M.
      • Buckett W.M.
      • Dean N.
      • Phillips S.J.
      • Tan S.L.
      The outcome of IVF-embryo transfer treatment in patients who develop three follicles or less.
      used sonographic criteria to define poor response and indicated a higher but not statistically significant live birth rate per cycle in those with more than three follicles (15.7% versus 4.2%).
      • Yih M.C.
      • Spandorfer S.D.
      • Rosenwaks Z.
      Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories.
      found a higher clinical pregnancy rate in women above 40 when five or more oocytes were retrieved. The Bologna criteria for poor responders (
      • Ferraretti A.P.
      • La Marca A.
      • Fauser B.C.J.M.
      • Tarlatzis B.
      • Nargund G.
      • Gianaroli L.
      ESHRE consensus on the definition of ‘poor response to ovarian stimulation for in vitro fertilization: the Bologna criteria.
      ) standardizes the definition of POR. Women aged 40 and over need only one additional criteria to meet the definition of POR, including either previous POR (≤3 oocytes with conventional stimulation) or an abnormal ovarian test reserve.
      Although one may assume that older women with good response carry a better prognosis for live birth, the effect of lower oocyte quality cannot be ignored. The aim of this study was to assess ovarian response based on the number of oocytes retrieved in accordance with the Bologna criteria and the number of dominant follicles, as significant predictors for live birth rate in women aged 40–43.

      Materials and methods

      Patient population

      This was a retrospective study conducted at a university hospital reproductive centre. The computerized database of the IVF unit for the years 2010 to 2015 was retrospectively analysed. The analysis included women who were 40–43 years of age, undergoing a non-donor IVF cycle. Pre-implantation genetic diagnosis (PGD), oocyte donation, in-vitro maturation (IVM) and natural IVF cycles were excluded. Women older than 43 were not treated, according to clinic policy. The study received Institutional Review Board approval on 16 May 2013 (reference number 13–053-SDR).
      IVF was publicly funded during the study period. According to the clinic policy, all patients with at least one follicle underwent ovum pickup. The outcome measures were calculated for women with at least one oocyte collected (per oocyte pickup). We analysed the primary outcome measures according to two accepted definitions for POR to stimulation: the first complies with the Bologna criteria – ≤ 3 oocytes retrieved and age 40 and above (
      • Ferraretti A.P.
      • La Marca A.
      • Fauser B.C.J.M.
      • Tarlatzis B.
      • Nargund G.
      • Gianaroli L.
      ESHRE consensus on the definition of ‘poor response to ovarian stimulation for in vitro fertilization: the Bologna criteria.
      ); the second is based on ultrasonographic findings of ≤3 dominant follicles (>14 mm in diameter) imaged 24–48 h prior to human chorionic gonadotrophin (HCG) administration (potential POR) (
      • Biljan M.M.
      • Buckett W.M.
      • Dean N.
      • Phillips S.J.
      • Tan S.L.
      The outcome of IVF-embryo transfer treatment in patients who develop three follicles or less.
      ,
      • Fridström M.
      • Akerlöf E.
      • Sjöblom P.
      • Hillensjö T.
      Serum levels of luteinizing and follicle-stimulating hormones in normal and poor-responding patients undergoing ovarian stimulation with urofollitropin after pituitary downregulation.
      ).
      The primary outcome measure was live birth. Secondary outcome measures included IVF protocol parameters, embryo development and baseline ovarian reserve test results. A second analysis was conducted for women over 40 undergoing their first IVF cycle. In addition, we searched for the outcome of poor responders in their first cycle with one or more subsequent IVF cycles. Those who had ≤3 oocytes in all subsequent cycles were defined as persistent poor responders and were compared with women with at least one subsequent cycle with good response. The outcome of women with cryopreserved embryos that underwent cryopreserved embryo transfer was also analysed.

      Ovarian stimulation protocol

      Ovarian stimulation was performed by means of one of the following protocols: microdose-flare protocol, fixed gonadotrophin-releasing hormone (GnRH) antagonist protocol and mid-luteal long GnRH agonist protocol. Briefly, ovarian stimulation was performed with gonadotrophins (Gonal-F, EMD-Serono Inc., Canada; Puregon, Merck Inc., Canada; Menopur, Ferring Pharmaceuticals Inc., Canada), ovulation was suppressed with GnRH antagonist (Cetrotide, EMD-Serono Inc.; Orgalutran, Merck Inc.) or GnRH agonist (Superfact, Sanofi-Aventis Inc., Canada). No standard stimulation protocol is used for patients with POR in our clinic; protocol and gonadotrophin dose were based on AFC, Day 3 FSH and the results of previous IVF cycles. Gonadotrophin dose was ≥300 IU FSH per day. After 5–7 days of stimulation, FSH dose was adjusted based on ultrasound scan and serum oestradiol level. The maximal dose of FSH was 600 IU. When ideally two follicles attained a mean diameter of 17 mm, 250 µg of human recombinant chorionic gonadotrophin was administered (Ovidrel, EMD-Serono Inc.). Oocyte retrieval by an ultrasound guided transvaginal approach was scheduled 36–38 h later.

      Embryo culture

      Oocytes were fertilized by either conventional IVF or intracytoplasmic sperm injection (ICSI), according to the clinical indication. Fertilization was assessed 16–18 h after insemination for the appearance of two distinct pronuclei and two polar bodies. The zygotes were cultured in cleavage medium (Cook Medical, Sydney, Australia). Embryonic development was assessed daily. Embryos were cultured to the blastocyst stage in the blastocyst medium (Cook Medical). According to our IVF laboratory protocol, if there were at least three good-quality embryos on Day 3, the embryo culture was extended to the blastocyst stage and the embryos were transferred on Day 5. Cleavage embryos were defined as good quality (Grade 1 or 2) if they had four cells on Day 2 and/or seven or eight cells on Day 3, contained <20% fragmentation and exhibited no apparent morphological abnormalities. Poor-quality embryos included fair quality (Grade 3) embryos, which had only two cells on Day 2, three to five cells on Day 3 and/or 20–50% fragmentation, and Grade 4 embryos with <3 cells by Day 3 and >50% fragmentation. For women with fewer than three good-quality embryos, embryo transfer was at Day 2–3. Supernumerary good-quality embryos were cryopreserved (
      • Zhang L.
      • Yilmaz A.
      • Chian R.-C.
      • Son W.-Y.
      • Zhang X.Y.
      • Kong D.
      • Dahan M.
      • Holzer H.
      • Tan S.L.
      • Ao A.
      Reliable preimplantation genetic diagnosis in thawed human embryos vitrified at cleavage stages without biopsy.
      ). The number of embryos transferred was determined according to the provincial guidelines at that time: up to two or three embryos and never more than three.

      Outcome measures

      The primary outcome was live birth rate per oocyte pickup. Live birth was defined as delivery of a live fetus ≥24 weeks of pregnancy. A pregnancy was defined by a positive serum β-HCG test 11–14 days after embryo transfer and clinical pregnancy was defined by ultrasound visualization of an intrauterine gestational sac with fetal heartbeat.

      Statistical analysis

      The data were not normally distributed, and so a non-parametric Wilcoxon signed-rank test was used to assess differences in population mean ranks of continuous variables. Categorical variables were compared by chi-squared test or Fisher's exact test, when appropriate. Descriptive statistics are given as median (interquartile range, IQR) for skewed data. Moreover, in order to examine which parameters are associated with live births, a stepwise multiple logistic regression model, adjusted for age, number of embryos transferred, availability of embryos for cryopreservation, Day 3 FSH, AFC, undergoing subsequent IVF cycles and good response defined by oocytes or by dominant follicles, was applied. A P-value <0.05 was considered significant. All statistical analysis was performed using JMP 12 for Macintosh (SAS Institute Inc., Cary, NC, USA).

      Results

      The medical records of 1278 women at the age of 40–43 with 1941 fresh IVF cycles were retrieved. The analysis included the outcomes of 1870 fresh IVF cycles (1212 women) with at least one oocyte retrieved. Poor response was documented in 509 cycles with ≤3 oocytes retrieved and in 851 cycles with ≤3 dominant follicles visualized ultrasonographically; of these, in 39 cycles only one dominant follicle was visualized. The average number of cycles per patient was 1.92 ± 0.9 (the number of women undergoing one, two, three and more than three cycles was 720, 667, 414 and 69, respectively). A total of 361 women had been pregnant before undergoing IVF and 360 had given birth (mean gravidity and parity were 0.6 and 0.34, respectively). Similar proportions of women with at least one previous pregnancy or live birth were found in women defined as good as compared with poor responders. Additional aetiology of infertility, except for patient age, was documented in 913 women: unexplained infertility (30%), decreased ovarian reserve (24%), male factor (24%), tubal factor (6%), ovulatory dysfunction (4%), multiple factors (9%) and endometriosis (3%) (Supplementary Table S1).
      The overall clinical pregnancy rate was 15.0% and the live birth rate was 9.4%. Clinical pregnancy and live birth rates analysed separately for women in their first IVF cycle were similar: 15.4% and 9.0%, respectively. Mean gestational age at delivery was 38 weeks (range 27–42 weeks), mean birth weight was 3188 g (range: 1060–4850 g). Ten women delivered twins at average week of delivery 36 (range 31–39 weeks) and 36.92% of clinical pregnancies spontaneously miscarried. Live birth per year of age is presented in Figure 1. In total, 204 women underwent subsequent cryopreserved embryo transfer, resulting in 17 live births (8.3%). Of these transfers only five were in women with POR, as defined by the number of oocytes retrieved (≤3), and these resulted in the birth of one baby.
      In this cohort, cycles were not cancelled as a result of POR and all patients with at least one follicle underwent ovum pickup. However, of the cycles in which at least one oocyte was retrieved, 199 cycles did not reach embryo transfer, 116 due to failed fertilization, 24 due to very poor embryo development of non-viable embryos, 16 due to the risk of ovarian hyperstimulation syndrome, 9 due to uterine factors (polyps, thin endometrium) and 34 in which sperm could not be retrieved. In 71 cycles (3.7%) no oocytes were retrieved.
      The differences in patient characteristics and protocol parameters between women with good response versus poor response are presented in Table 1. It is worth noting that women with a good response to ovarian stimulation, defined either by the number of oocytes or the number of dominant follicles, had a higher number of cleavage stage embryos, cycles with embryos available for cryopreservation and cycles with blastocyst transfers. The live birth per oocyte retrieval was 3.3 times higher (11.61% versus 3.54%, P < 0.001) in good responders with >3 oocytes collected, compared with 1.8 times higher (11.78% versus 6.58%, P < 0.001) in women with >3 dominant follicles when compared with women with fewer (Table 1).
      Table 1Differences in patient characteristics, protocol parameters and IVF outcome between women with good response versus poor response.
      Good response

      >3 oocytes
      Poor response

      ≤3 oocytes
      P-valueGood response

      >3 DF
      Poor response

      ≤3 DF
      P-value
      n13615091019851
      Age (years)41.13 ± 0.9841.37 ± 0.96<0.00141.14 ± 0.9741.26 ± 0.980.008
      Baseline ovarian reserve tests
      Day 3 FSH (IU/l)7.4 (6.0–8.8)8.2 (6.9–11.8)<0.0017.2 (5.9–8.6)8.2 (6.75–10.4)<0.001
      AFC12 (7–17)6 (4–8)<0.00112 (8–18)7 (5–11)<0.001
      Protocol
      MDF, n (%)698 (51.3)305 (59.9)0.001554 (54.4)451 (53.0)NS
      Long agonist, n (%)310 (22.8)75 (14.7)<0.001199 (19.5)185 (21.7)NS
      Antagonist, n (%)352 (25.9)129 (25.3)NS266 (26.1)215 (25.3)NS
      IVF protocol parameters
      Total FSH (IU)3600 (2358–4875)4500 (3150–5850)<0.0013450 (2250–4950)4050 (3000–5400)<0.001
      FSH (IU) per oocyte406 (232–720)2100 (1462–3600)<0.001366 (212–693)1200 (600–2250)<0.001
      Peak serum oestradiol (pmol/l)6300 (4539–9005)2482 (1626–3689)<0.0016620 (4989–12255)3261 (2253–5079)<0.001
      DF >14 mm5 (3–7)2 (1–3)<0.0016 (5–8)2 (1–3)<0.001
      Oocytes collected7 (5–11)2 (2–3)<0.0018 (6–12)3 (2–5)<0.001
      MII oocytes5 (4–8.5)2 (1–2)<0.0016 (4–9)3 (2–4)<0.001
      ICSI, n (%)1095 (80.46)406 (79.76)NS821 (80.57)680 (79.91)NS
      Two pronuclei (2PN)4 (2–6)1 (1–2)<0.0014 (2–7)2 (1–3)<0.001
      No. of cleavage stage embryos4 (2–6)1 (1–2)<0.0014 (2–6)2 (1–3)<0.001
      Embryo grade
      Grade of the best cleavage stage embryo transferred. Good quality: grade 1 or 2, fair quality: grade 3, poor quality: grade 4.
      Grade 1 or 2, n (%)627/888 (70.6)239/391 (61.1)0.002453/629 (72)414/650 (63.7)0.004
      Grade 3, n (%)256/888 (28.8)141/391 (36.1)0.018171/629 (27.2)224/650 (34.5)0.009
      Grade 4, n (%)4/888 (0.5)11/391 (2.8)0.0034/629 (0.6)10/650 (1.5)NS
      Embryo cryopreservation
      Number of cycles with embryo cryopreservation.
      , n (%)
      286 (21.01)5 (0.98)<0.001244 (23.95)47 (5.52)<0.001
      Cycles with blastocyst transfer, n (%)385 (28.3)7 (1.4)<0.001319 (31.3)73 (8.6)<0.001
      No. of embryos transferred2 (1–2)1 (1–2)<0.0012 (1–2)1 (1–2)<0.001
      IVF cycle outcomes
      No embryo transfer, n (%)88 (6.47)111 (21.81)<0.00171 (6.97)128 (15.04)<0.001
      Biochemical pregnancy, n (%)336 (24.69)51 (10)<0.001257 (25.22)130 (15.28)<0.001
      Clinical pregnancy, n (%)247 (18.1)32 (6.3)<0.001185 (18.16)94 (11.05)<0.001
      Live birth, n (%)158 (11.61)18 (3.54)<0.001120 (11.78)56 (6.58)<0.001
      Miscarriage, n (%)89/247 (36)14/32 (43.75)NS65/185 (35.14)38/94 (40.43)NS
      Data presented as mean ± standard deviation or median (interquartile range).
      AFC = antral follicle count; DF = dominant follicle; MDF = micro-dose flare; MII = metaphase II; NS = not significant.
      a Grade of the best cleavage stage embryo transferred. Good quality: grade 1 or 2, fair quality: grade 3, poor quality: grade 4.
      b Number of cycles with embryo cryopreservation.
      Similar differences in protocol parameters and cycle outcome were found in a subgroup analysis for first IVF cycle only. Higher live birth rates were recorded in good responders, whether this was defined by oocytes collected or dominant follicles visualized ultrasonographically (Table 2). More cycles in poor responders did not attain embryo transfer due to failed fertilization and very poor embryo development.
      Table 2Differences in patient characteristics, protocol parameters and outcome in the first IVF cycle between women with good response versus poor response.
      Good response

      >3 oocytes
      Poor response

      ≤3 oocytes
      P-valueGood response

      >3 DF
      Poor response

      ≤3 DF
      P-value
      n561211411360
      Age (years)41.07 ± 0.9841.33 ± 0.990.00141.09 ± 0.9841.19 ± 1.00NS
      Baseline ovarian reserve tests
      Day 3 FSH (IU/l)7.3 (5.9–8.8)8.4 (7.45–16.45)0.0017.2 (5.9–8.55)8.3 (6.68–11.33)0.002
      AFC11 (7–17)5.5 (2–8.75)<0.00112 (8–17)7 (5–13)<0.001
      IVF protocol parameters
      Total FSH (IU)3000 (2025–4500)4050 (3000–5737)<0.0013000 (2025–4800)3600 (2700–4950)<0.001
      FSH units per oocyte (IU)366 (197–652)2200 (1350–3600)<0.001350 (180–616)1012 (540–2250)<0.001
      Peak serum oestradiol (pmol/l)6420 (4724–9403)2379 (1512–3371)<0.0016689 (5081–9930)3317 (2381–5244)<0.001
      DF >14 mm5 (3–7)2 (1–3)<0.0016 (5–8)2 (2–3)<0.001
      Oocytes collected7 (5–11)2 (1–3)<0.0018 (5–12)4 (2–6)<0.001
      MII oocytes5 (4–9)2 (1–2)<0.0016 (4–10)3 (2–4)<0.001
      ICSI, n (%)391 (69.7)152 (72.04)NS286 (69.6)257 (71.39)NS
      Two pronuclei (2PN)4 (2–6)1 (1–2)<0.0014 (2–7)2 (1–3)<0.001
      No. of cleavage stage embryos4 (2–6)1 (1–2)<0.0014 (2–7)2 (1–3)<0.001
      Embryo cryopreservation
      Number of cycles with embryo cryopreservation.
      , n (%)
      143 (25.49)2 (0.95)<0.001120 (29.2)24 (6.67)<0.001
      Cycles with blastocyst transfer, n (%)183 (32.6)2 (0.95)<0.001152 (37)34 (9.4)<0.001
      No. of embryos transferred2 (1–2)1 (1–2)<0.0012 (1–2)1 (1–2)0.02
      IVF cycle outcomes
      No embryo transfer, n (%)31 (5.53)41 (19.43)<0.00127 (6.57)45 (12.50)0.005
      Biochemical pregnancy, n (%)144 (25.67)20 (9.48)<0.001103 (25.06)61 (16.94)0.006
      Clinical pregnancy, n (%)106 (18.89)13 (6.16)<0.00172 (17.52)47 (13.06)NS
      Live birth, n (%)69 (12.30)7 (3.32)<0.00151 (12.41)25 (6.94)0.01
      Miscarriage, n (%)37/106 (34.9)6/13 (46.15)NS21/72 (29.17)22/47 (46.8)NS
      Data presented as mean ± standard deviation or median (interquartile range).
      AFC = antral follicle count; DF = dominant follicle; MII = metaphase II; NS = not significant.
      a Number of cycles with embryo cryopreservation.
      Outcomes of 353 women undergoing their first IVF cycle who did not achieve pregnancy and who had one or more subsequent cycles were analysed. Respectively, 225, 115 and 13 women had one, two and three subsequent IVF trails. Forty per cent (37/93) of women who responded poorly in their first IVF cycle, as defined by the number of oocytes collected, were good responders in the second cycle. Of these 37, 10 had no change in their stimulation protocol, 5 had an increased gonadotrophin dose and 22 had a different stimulation protocol. Nine per cent (5/54) from those who responded poorly in their first two cycles were good responders in the third cycle. Fifty-one women (54.8%) were persistent poor responders. Live birth rate per patient was comparable in persistent poor responders and women with at least one subsequent cycle with good ovarian response (9.8% [5/51] versus 11.9% [5/42]). A similar live birth rate of 8.7% (20/229) was recorded in good responders in their first cycle. Live birth rates for poor responders defined by the number of oocytes were 3.3% (7/211), 8.8% (8/91), 6.9% (2/29) and 0% (0/1) for the first, second, third and fourth IVF cycle, respectively.
      The association between live birth and age, availability of embryos for cryopreservation, number of cryopreserved embryos, AFC, Day 3 FSH, undergoing subsequent IVF cycles, good response defined by oocytes or number of dominant follicles, was analysed using a stepwise logistic regression analysis (Table 3). In the analysis of all IVF cycles, ovarian response defined by >3 oocytes collected (odds ratio [OR], 2.0; 95% confidence interval [CI], 1.18 to 3.54), but not by the number of mature follicles, was associated with live birth. The following factors were also found to be significantly associated with live birth: age (OR, 0.65; 95% CI, 0.54 to 0.78), number of embryos transferred (OR, 1.83; 95% CI, 1.42 to 2.37), cycles with cryopreserved embryos (OR, 2.6; 95% CI, 1.78 to 3.81) and women undergoing more than one IVF cycle (OR, 0.26; 95% CI, 0.19 to 0.37). In a subgroup analysis of women undergoing their first cycle: age (OR, 0.64; 95% CI, 0.49 to 0.85), number of embryos transferred (OR, 1.56; 95% CI, 1.06 to 2.29) and embryos available for cryopreservation (OR, 2.64; 95% CI, 1.5 to 4.64) were significant predictors for live birth rate.
      Table 3Odds ratio and 95% confidence intervals for predictors of live birth in women over 40 years undergoing IVF.
      Adjusted odds ratio95% confidence intervalP-value
      For all IVF cycles
      >3 oocytes retrieved2.01.18–3.540.009
      Age0.650.54–0.78
      Per unit change.
      <0.001
      Number of embryos transferred1.831.42–2.37
      Per unit change.
      <0.001
      Availability of embryos to cryopreserve2.601.78–3.81<0.001
      Undergoing more than one IVF cycle0.260.19–0.37<0.001
      For first cycle only
      Age0.640.49–0.85
      Per unit change.
      0.001
      Number of embryos transferred1.561.06–2.29
      Per unit change.
      0.021
      Availability of embryos to cryopreserve2.641.5–4.64<0.001
      >3 oocytes retrieved2.210.94–5.22NS
      Stepwise logistic regression to analyse the association between live birth and age, number of embryos transferred, availability of embryos for cryopreservation, antral follicle count, Day 3 FSH, undergoing subsequent IVF cycles, good response defined by oocytes or number of dominant follicles.
      NS = not significant.
      a Per unit change.

      Discussion

      In general, women with good ovarian response during IVF would have more oocytes, more embryos and a higher chance of pregnancy and birth. Nevertheless, with age, both oocyte quantity and quality are compromised (
      • Faddy M.J.
      • Gosden R.G.
      • Gougeon A.
      • Richardson S.J.
      • Nelson J.F.
      Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause.
      ,
      • Hassold T.
      • Hunt P.
      Maternal age and chromosomally abnormal pregnancies: what we know and what we wish we knew.
      ). To what extent does poor oocyte quality in this subgroup of IVF patients affect the live birth rate? In this study, we found that the live birth rate is up to 3.3 times higher in older women who had good responses, defined by >3 oocytes collected. Alternatively, if ovarian response is estimated by the number of dominant follicles visualized ultrasonographically, the live birth rate is 1.8 times higher in women with >3 dominant follicles. Similar live birth rates were found when analysing women undergoing their first IVF cycle.
      A single episode of POR to stimulation in the first IVF cycle has a limited predictive value for the outcomes of subsequent cycles. The results of this study do not support using it to recommend against further cycles. Fifty-five per cent of women with ≤3 oocytes in their first IVF cycle will respond poorly to ovarian stimulation in subsequent cycles. This is in accordance with previous studies which found that the recurrence rate of poor response was 54–62% (
      • Klinkert E.R.
      • Broekmans F.J.M.
      • Looman C.W.N.
      • Te Velde E.R.
      A poor response in the first in vitro fertilization cycle is not necessarily related to a poor prognosis in subsequent cycles.
      ,
      • Peñarrubia J.
      • Fábregues F.
      • Manau D.
      • Creus M.
      • Carmona F.
      • Casamitjana R.
      • Vanrell J.A.
      • Balasch J.
      Previous cycle cancellation due to poor follicular development as a predictor of ovarian response in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment.
      ). Remarkably, it appears that the rate of persistent poor responders is not affected by the older age of participants in this study. Furthermore, comparable live birth rates in persistent poor responders versus women with at least one cycle with good response also does not support withdrawal from further IVF attempts in women who responded poorly in their first IVF cycle. The live birth rates in the second and third IVF cycle in women who were persistent poor responders was 7–8% per cycle with oocyte pickup. This result further supports our conclusion that poor response in women over 40 undergoing their first cycle is not a good indicator for the outcome of subsequent IVF trials.
      As expected, IVF protocol parameters were related to ovarian response. Good responders required less total FSH dose and the FSH per oocyte was also significantly lower. A lower birth rate in poor responders was the result of a higher number of cycles without embryo transfer, fewer embryos available for transfer, lower embryo quality and fewer blastocyst stage transfers. Nevertheless, poor response cannot predict a miscarriage as the miscarriage rate was similar between all groups. Good response defined by >3 oocytes collected, but not according to the number of dominant follicles visualized ultrasonographically, was found to be an independent predictor for live birth.
      The cohort of women that responded poorly to ovarian stimulation had several negative pretreatment prognostic factors. The prevalence of unexplained, male factor, ovulatory dysfunction infertility was lower, while decreased ovarian reserve and multifactor infertility were significantly higher in poor responders. Furthermore, the more favourable prognosis of good responders is reflected in their ovarian reserve tests. The differences in ovarian reserve tests were more prominent when analysed according to the AFC, although the differences in Day 3 FSH were also statistically significant. AMH and AFC have limited accuracy and a high false positive rate of 10–20% for predicting ovarian reserve (
      • Broekmans F.J.
      • Kwee J.
      • Hendriks D.J.
      • Mol B.W.
      • Lambalk C.B.
      A systematic review of tests predicting ovarian reserve and IVF outcome.
      ,
      • La Marca A.
      • Sighinolfi G.
      • Radi D.
      • Argento C.
      • Baraldi E.
      • Artenisio A.C.
      • Stabile G.
      • Volpe A.
      Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).
      ). They were found to correlate with the response to ovarian stimulation, but were poor predictors for pregnancy and the live birth rate (
      • Fauser B.C.J.M.
      • Diedrich K.
      • Devroey P.
      Evian Annual Reproduction Workshop Group 2007
      Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation.
      ). For that reason, the ESHRE consensus suggests using both the women's age as well as ovarian response to stimulation as post hoc tests to confirm POR (
      • Ferraretti A.P.
      • La Marca A.
      • Fauser B.C.J.M.
      • Tarlatzis B.
      • Nargund G.
      • Gianaroli L.
      ESHRE consensus on the definition of ‘poor response to ovarian stimulation for in vitro fertilization: the Bologna criteria.
      ).
      The live birth rate reported in this study is in accordance with previous studies that reported a birth rate of 4.0–7.6% at 43 years of age and 9.0–13.9% at 40 years of age (
      • Klipstein S.
      • Regan M.
      • Ryley D.A.
      • Goldman M.B.
      • Alper M.M.
      • Reindollar R.H.
      One last chance for pregnancy: a review of 2,705 in vitro fertilization cycles initiated in women age 40 years and above.
      ,
      • Tsafrir A.
      • Simon A.
      • Revel A.
      • Reubinoff B.
      • Lewin A.
      • Laufer N.
      Retrospective analysis of 1217 IVF cycles in women aged 40 years and older.
      ). Moreover, the largest published single-centre study was conducted in 2003–2008 and indicated a live birth rate per oocyte pickup of 2.4% for 43 years to 11% at 40 years of age. The live birth rates stratified by age were comparable with our results.
      • Sunkara S.K.
      • Rittenberg V.
      • Raine-Fenning N.
      • Bhattacharya S.
      • Zamora J.
      • Coomarasamy A.
      Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles.
      found a live birth rate of 1–6% for women over 40 with one to three oocytes collected, respectively. Poor responders were not compared with good responders per se and differences in protocol parameters and other IVF outcomes were not reported in that large national database analysis. Only very few studies analysed the effect of ovarian response to stimulation on the live birth rate using different methodology and cut-off values for poor response. Most importantly, they were published before the ESHRE consensus on the definition of POR, thus they did not use the accepted cut-off values.
      • Biljan M.M.
      • Buckett W.M.
      • Dean N.
      • Phillips S.J.
      • Tan S.L.
      The outcome of IVF-embryo transfer treatment in patients who develop three follicles or less.
      reported a higher live birth rate in women over 40 with more than three follicles. However, due to the small sample size, it lacked statistical power.
      • Ciray H.N.
      • Ulug U.
      • Tosun S.
      • Erden H.F.
      • Bahceci M.
      Outcome of 1114 ICSI and embryo transfer cycles of women 40 years of age and over.
      found a higher delivery rate in women 40 years of age and over for those with more than six oocytes retrieved (15% versus 5.9%).
      • Tsafrir A.
      • Simon A.
      • Revel A.
      • Reubinoff B.
      • Lewin A.
      • Laufer N.
      Retrospective analysis of 1217 IVF cycles in women aged 40 years and older.
      found higher pregnancy rates for women with more than five oocytes collected; however, the live birth rate was not reported. Similarly,
      • Yih M.C.
      • Spandorfer S.D.
      • Rosenwaks Z.
      Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories.
      also found significantly lower pregnancy rates in women with ≤4 oocytes retrieved, but only in women with normal ovarian reserve tests. Because the miscarriage rate in that age group is very high, reports without live birth figures give us limited prognostic value for the ultimate outcome of IVF.
      The results of our multivariate analysis are in accordance with those of
      • Polyzos N.P.
      • Nwoye M.
      • Corona R.
      • Blockeel C.
      • Stoop D.
      • Haentjens P.
      • Camus M.
      • Tournaye H.
      Live birth rates in Bologna poor responders treated with ovarian stimulation for IVF/ICSI.
      , who found that the number of oocytes retrieved was a significant predictor associated with live birth in poor responders fulfilling the Bologna criteria across a wide range of ages. Our results confirm their findings in women over 40 years of age. However, other parameters like age, the number of embryos transferred and the availability of embryos for cryopreservation were also found to be associated with live birth. These differences can be explained by the larger sample size of our study, inclusion only of women over 40 and different adjustment for confounding factors in the logistic regression.
      The results of this study show that the number of oocytes collected, and not the number of dominant follicles visualized ultrasonographically, is an independent predictor for live birth in women over 40. It could be explained by variability in follicle measurements by ultrasound. Moreover, oocytes could not be retrieved from some follicles during oocyte retrieval. Thus POR, as defined by the Bologna criteria, according to the number of oocytes retrieved, is a better marker for successful IVF cycles.
      This is not the first study analysing IVF outcome in this age group. Nevertheless, most of the previous reports were from 1995 to 2008, thus this study represents the results of a modern IVF unit. This study also contributes to the limited available data on the success rate of women who responded poorly in their first IVF cycle who underwent further cycles. Because cycles were not cancelled prior to ovum pickup due to poor response, this analysis provides a good estimate of the success rate for this subgroup of patients, without the risk of bias caused by cycles cancelled due to poor response. Furthermore, although the predictive power of the number of oocytes was reported, comparison of poor responders versus good responders was not done according to the Bologna criteria. In addition, we analysed the data according to the number of dominant follicles for the added value of predicating the success rate of the cycle before ovum pickup. This study is limited by its retrospective design. AMH values could not be analysed as they are not part of the provincial routine tests, although it was suggested that AFC is a reliable marker to predict ovarian response to stimulation (
      • Hsu A.
      • Arny M.
      • Knee A.B.
      • Bell C.
      • Cook E.
      • Novak A.L.
      • Grow D.R.
      Antral follicle count in clinical practice: analysing clinical relevance.
      ).
      In conclusion, poor response to ovarian stimulation in women over 40 years of age, as defined by the number of oocytes retrieved and not by the number of dominant follicles visualized ultrasonographically, is an independent predictor for live birth in IVF. POR in a first IVF cycle cannot be used to predict the recurrence of poor response in subsequent cycles. These women should be informed of their prognosis.

      Acknowledgement

      The authors would like to thank Robbie Dolev for editorial assistance.

      Appendix. Supplementary material

      The following is the supplementary data to this article:

      References

        • Biljan M.M.
        • Buckett W.M.
        • Dean N.
        • Phillips S.J.
        • Tan S.L.
        The outcome of IVF-embryo transfer treatment in patients who develop three follicles or less.
        Hum. Reprod. 2000; 15: 2140-2144
        • Broekmans F.J.
        • Kwee J.
        • Hendriks D.J.
        • Mol B.W.
        • Lambalk C.B.
        A systematic review of tests predicting ovarian reserve and IVF outcome.
        Hum. Reprod. Update. 2006; 12: 685-718
        • Ciray H.N.
        • Ulug U.
        • Tosun S.
        • Erden H.F.
        • Bahceci M.
        Outcome of 1114 ICSI and embryo transfer cycles of women 40 years of age and over.
        Reprod. Biomed. Online. 2006; 13: 516-522
        • Crawford S.
        • Boulet S.L.
        • Kawwass J.F.
        • Jamieson D.J.
        • Kissin D.M.
        Cryopreserved oocyte versus fresh oocyte assisted reproductive technology cycles, United States, 2013.
        Fertil. Steril. 2017; 107: 110-118
        • Faddy M.J.
        • Gosden R.G.
        • Gougeon A.
        • Richardson S.J.
        • Nelson J.F.
        Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause.
        Hum. Reprod. 1992; 7: 1342-1346
        • Fauser B.C.J.M.
        • Diedrich K.
        • Devroey P.
        • Evian Annual Reproduction Workshop Group 2007
        Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation.
        Hum. Reprod. Update. 2007; 14: 1-14
        • Ferraretti A.P.
        • La Marca A.
        • Fauser B.C.J.M.
        • Tarlatzis B.
        • Nargund G.
        • Gianaroli L.
        ESHRE consensus on the definition of ‘poor response to ovarian stimulation for in vitro fertilization: the Bologna criteria.
        Hum. Reprod. 2011; 26: 1616-1624
        • Fridström M.
        • Akerlöf E.
        • Sjöblom P.
        • Hillensjö T.
        Serum levels of luteinizing and follicle-stimulating hormones in normal and poor-responding patients undergoing ovarian stimulation with urofollitropin after pituitary downregulation.
        Gynecol. Endocrinol. 1997; 11: 25-28
        • Hassold T.
        • Hunt P.
        Maternal age and chromosomally abnormal pregnancies: what we know and what we wish we knew.
        Curr. Opin. Pediatr. 2009; 21: 703-708
        • Hsu A.
        • Arny M.
        • Knee A.B.
        • Bell C.
        • Cook E.
        • Novak A.L.
        • Grow D.R.
        Antral follicle count in clinical practice: analysing clinical relevance.
        Fertil. Steril. 2011; 95: 474-479
        • Klinkert E.R.
        • Broekmans F.J.M.
        • Looman C.W.N.
        • Te Velde E.R.
        A poor response in the first in vitro fertilization cycle is not necessarily related to a poor prognosis in subsequent cycles.
        Fertil. Steril. 2004; 81: 1247-1253
        • Klipstein S.
        • Regan M.
        • Ryley D.A.
        • Goldman M.B.
        • Alper M.M.
        • Reindollar R.H.
        One last chance for pregnancy: a review of 2,705 in vitro fertilization cycles initiated in women age 40 years and above.
        Fertil. Steril. 2005; 84: 435-445
        • La Marca A.
        • Sighinolfi G.
        • Radi D.
        • Argento C.
        • Baraldi E.
        • Artenisio A.C.
        • Stabile G.
        • Volpe A.
        Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).
        Hum. Reprod. Update. 2010; 16: 113-130
        • Lass A.
        • Croucher C.
        • Duffy S.
        • Dawson K.
        • Margara R.
        • Winston R.M.L.
        One thousand initiated cycles of in vitro fertilization in women > or = 40 years of age.
        Fertil. Steril. 1998; 70: 1030-1034
        • Miao Y.-L.
        • Kikuchi K.
        • Sun Q.-Y.
        • Schatten H.
        Oocyte ageing: cellular and molecular changes, developmental potential and reversal possibility.
        Hum. Reprod. Update. 2009; 15: 573-585
        • Peñarrubia J.
        • Fábregues F.
        • Manau D.
        • Creus M.
        • Carmona F.
        • Casamitjana R.
        • Vanrell J.A.
        • Balasch J.
        Previous cycle cancellation due to poor follicular development as a predictor of ovarian response in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment.
        Hum. Reprod. 2005; 20: 622-628
        • Polyzos N.P.
        • Nwoye M.
        • Corona R.
        • Blockeel C.
        • Stoop D.
        • Haentjens P.
        • Camus M.
        • Tournaye H.
        Live birth rates in Bologna poor responders treated with ovarian stimulation for IVF/ICSI.
        Reprod. Biomed. Online. 2014; 28: 469-474
        • Serour G.
        • Mansour R.
        • Serour A.
        • Aboulghar M.
        • Amin Y.
        • Kamal O.
        • Al-Inany H.
        • Aboulghar M.
        Analysis of 2,386 consecutive cycles of in vitro fertilization or intracytoplasmic sperm injection using autologous oocytes in women aged 40 years and above.
        Fertil. Steril. 2010; 94: 1707-1712
        • Sunderam S.
        • Kissin D.M.
        • Crawford S.B.
        • Folger S.G.
        • Jamieson D.J.
        • Warner L.
        • Barfield W.D.
        Assisted reproductive technology surveillance – United States, 2014.
        MMWR Surveill. Summ. 2017; 66: 1-24
        • Sunkara S.K.
        • Rittenberg V.
        • Raine-Fenning N.
        • Bhattacharya S.
        • Zamora J.
        • Coomarasamy A.
        Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles.
        Hum. Reprod. 2011; 26: 1768-1774
        • Tsafrir A.
        • Simon A.
        • Revel A.
        • Reubinoff B.
        • Lewin A.
        • Laufer N.
        Retrospective analysis of 1217 IVF cycles in women aged 40 years and older.
        Reprod. Biomed. Online. 2007; 14: 348-355
        • Yih M.C.
        • Spandorfer S.D.
        • Rosenwaks Z.
        Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories.
        Fertil. Steril. 2005; 83: 24-29
        • Zhang L.
        • Yilmaz A.
        • Chian R.-C.
        • Son W.-Y.
        • Zhang X.Y.
        • Kong D.
        • Dahan M.
        • Holzer H.
        • Tan S.L.
        • Ao A.
        Reliable preimplantation genetic diagnosis in thawed human embryos vitrified at cleavage stages without biopsy.
        J. Assist. Reprod. Genet. 2011; 28: 597-602

      Biography

      Yoni Cohen received his MD from Tel Aviv University and his PhD from the Weizmann Institute of Science, Israel. He completed his residency in OBGYN at Tel Aviv Sourasky Medical Center, Israel, in 2015. He is currently doing postgraduate training in reproductive endocrinology and infertility at McGill University, Canada.
      Key message
      Poor response to stimulation in the first IVF cycle has a limited predictive value for the outcomes of subsequent cycles in women over 40 years. Poor response, defined by number of oocytes retrieved, and not by number of dominant follicles, is an independent predictor for births for women over 40.